In Vitro Induction of Apoptosis in Human Lymphocytes By Stx1 From E. Coli O157:H7

(Kadhm Adel Hadi and Shayma’a Jabbar Raisan)

---

Abstract

Background: Shiga toxin 1 (Stx1), produced by Escherichia coli O157:H7 and related strains, is a potent cytotoxin implicated in severe clinical conditions such as hemolytic uremic syndrome (HUS), acute kidney injury, and chronic urinary tract infections. While its mechanisms of protein synthesis inhibition and apoptosis induction are well characterized in epithelial and endothelial cells, its effects on immune cells particularly human lymphocytes remain underexplored. This study aimed to investigate the apoptotic response of human peripheral blood lymphocytes to Stx1 exposure in vitro to better understand the immunomodulatory potential of the toxin. Lymphocytes were isolated from the peripheral blood of healthy donors using density gradient centrifugation. Cells were treated with 5 µL of Stx1 toxin at three concentrations (0.25 ng/mL, 0.5 ng/mL, and 1 ng/mL) and incubated with 5 µL of acridine orange/ethidium bromide staining solution at four-time intervals (0 h, 4 h, 12 h, and 24 h). A control group of untreated cells was included at each time point. Apoptotic changes were assessed via fluorescence microscopy based on nuclear staining patterns. A substantial increase in apoptosis was observed in Stx1-treated lymphocytes compared to controls. The effect was both dose- and time-dependent, with the highest apoptotic rate noted at 1 ng/mL after 24 h. Control groups showed minimal baseline apoptosis. Stx1 exerts a strong pro-apoptotic effect on human lymphocytes in vitro, suggesting a potential role in immune suppression and pathogenesis during E. coli O157:H7 infections. These findings underscore the importance of considering lymphocyte impairment in the clinical course of HUS and related conditions.
KEYWORDS
Biosynthesis, caspase, centrifugation, clinical, protein, time

PDF

References

Albadery, A.A., Al-Amara, S.S.M. and Al-Abdullah, A.A.-A.R. (2023). Phenotyping and genotyping evaluation of E. coli produces carbapenemase isolated from cancer patients in Al-Basrah, Iraq. Archives of Razi Institute, 78(3), 823–9. DOI: 10.22092/ARI.2022.359869.2493.
Babolhavaeji, K., Ahmadi, A. and Shokoohizadeh, L. (2024). Shiga toxin: Emerging producer strains, prophylactic approaches, and application in cancer therapy. Journal of Cancer Prevention, 29(4), 120–9. DOI: 10.15430/JCP.24.010.
Bova, R.A., Lamont, A.C., Picou, T.J., Ho, V.B., Gilchrist, K.H. and Melton-Celsa, A.R. (2023). Shiga toxin (Stx) type 1a and Stx2a translocate through a three-layer intestinal model. Toxins, 15(3), 207. DOI: 10.3390/toxins15030207.
Boyum, A. (1986). Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest, 21(n/a), 77–89.
Creagh, E.M., Conroy, H. and Martin, S.J. (2003). Caspase‐activation pathways in apoptosis and immunity. Immunological Reviews, 193(1), 10–21. DOI: 10.1034/j.1600-065X.2003.00048.x.
Hames, B.D. (1998). Gel Electrophoresis of proteins: A practical Approach. Oxford, United Kingdom.
Hardany, M.J., Al-Abdullah, A.A., Al-Amara, S.S. and Makki, H.M.A. (2020). Molecular investigation of gram negative bacteria extended spectrum β-lactamase in haemodialysis patients in Basrah Province, Iraq. Plant Archives, 20(1), 1573–6.
Haris, R. (1969). Rapid preparation for lymphocytes for tissue typing. Lancet, 327(n/a), 7615–9.
Harrison, L.M., Cherla, R.P., van den Hoogen, C., van Haaften, W.C., Lee, S.Y. and Tesh, V.L. (2005). Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells. Microbial Pathogenesis, 38(2-3), 63–76. DOI: 10.1016/j.micpath.2004.12.003.
Jamshidi, A., Rad, M. and Zeinali, T. (2015). Detection of Shiga toxin-producing Escherichia coli (STEC) in faeces of healthy calves in Mashhad, Iran. Archives of Razi Institute, 70(3), 179–85. DOI: 10.7508/ari.2015.03.006.
Johannes, L., and Römer, W. (2010). Shiga toxins—from cell biology to biomedical applications. Nature Reviews Microbiology, 8(2), 105–16. DOI: 10.1038/nrmicro2279.
Jones, N.L., Islur, A., Haq, R., Mascarenhas, M., Karmali, M.A., Perdue, M.H. ...and Sherman, P.M. (2000). Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. American Journal of Physiology-Gastrointestinal and Liver Physiology, 278(5), G811–9. DOI: 10.1152/ajpgi.2000.278.5.G811.
Karpman, D., Håkansson, A., Perez, M.T.R., Isaksson, C., Carlemalm, E., Caprioli, A. and Svanborg, C. (1998). Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infection and Immunity, 66(2), 636–44. DOI: 10.1128/iai.66.2.636-644.1998.
Kojio, S., Zhang, H.M., Ohmura, M., Gondaira, F., Kobayashi, N. and Yamamoto, T. (2000). Caspase-3 activation and apoptosis induction coupled with the retrograde transport of Shiga toxin: inhibition by brefeldin A. FEMS Immunology & Medical Microbiology, 29(4), 275–81. DOI: 10.1111/j.1574-695X.2000.tb01534.x.
Kurohane, K., Nagano, K., Nakanishi, K., Iwata, K., Miyake, M. and Imai, Y. (2014). Shiga toxin-induced apoptosis is more efficiently inhibited by dimeric recombinant hybrid-IgG/IgA immunoglobulins than by the parental IgG monoclonal antibodies. Virulence, 5(8), 819–24. DOI: 10.4161/21505594.2014.973804.
Lee, S.-Y., Cherla, R.P., Caliskan, I. and Tesh, V.L. (2005). Shiga toxin 1 induces apoptosis in the human myelogenous leukemia cell line THP-1 by a caspase-8-dependent, tumor necrosis factor receptor-independent mechanism. Infection and Immunity, 73(8), 5115–26. DOI: 10.1128/iai.73.8.5115-5126.2005.
Luvisetto, S. (2020). Botulinum toxin and neuronal regeneration after traumatic injury of central and peripheral nervous system. Toxins, 12(7), 434. DOI: 10.3390/toxins12070434.
O'Brien, A.D. and Holmes, R.K. (1987). Shiga and Shiga-like toxins. Microbiological Reviews, 51(2), 206–20. DOI: 10.1128/mr.51.2.206-220.1987.
Ramegowda, B. and Tesh, V.L. (1996). Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infection and Immunity, 64(4), 1173–80. DOI: 10.1128/iai.64.4.1173-1180.1996.
Salvioli, S., Ardizzoni, A., Franceschi, C. and Cossarizza, A. (1997). JC-1, but not DiOC6 (3) or rhodamine 123, is a reliable fluorescent probe to assess ΔΨ changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis. FEBS letters, 411(1), 77–82. DOI: 10.1016/s0014-5793(97)00669-8.
Tesh, V.L. and O'brien, A.D. (1991). The pathogenic mechanisms of Shiga toxin and the Shiga‐like toxins. Molecular Microbiology, 5(8), 1817–22. DOI: 10.1111/j.1365-2958.1991.tb00805.x.
Ting, A. and Morris, P.J. (1971). A technique for lymphocyte preparation from stored heparinized blood. Vox Sanguinis, 20(6), 561–3.
Wang, X., Yu, D., Chui, L., Zhou, T., Feng, Y., Cao, Y. and Zhi, S. (2024). A comprehensive review on Shiga toxin subtypes and their niche-related distribution characteristics in Shiga-Toxin-producing E. coli and other bacterial hosts. Microorganisms, 12(4), 687. DOI: 10.3390/microorganisms12040687.